Luminal B Breast Cancer: Molecular Characterization, Clinical Management, and Future Perspectives
2014 · Journal of Clinical Oncology · 414 citations
https://doi.org/10.1200/jco.2013.54.1870
L
Lina Pugliano
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
33
Papers
890
Citations
8
h-index
8
i10-index
Lina Pugliano is an academic researcher from Royal North Shore Hospital. The author has contributed to research in topics: Breast Cancer Treatment Studies & HER2/EGFR in Cancer Research & Cancer Treatment and Pharmacology. The author has an h-index of 8, co-authored 29 publications.
Papers by this author
worksPertuzumab: new hope for patients with HER2-positive breast cancer
2012 · Annals of Oncology · 164 citations
https://doi.org/10.1093/annonc/mds328
Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer
2016 · Annals of Oncology · 59 citations
https://doi.org/10.1093/annonc/mdw132
HER2-overexpressing breast cancer
2011 · Current Opinion in Oncology · 18 citations
https://doi.org/10.1097/cco.0b013e32834bd4c9
Management of patients treated with pertuzumab in the Australian clinical practice setting
2016 · Asia-Pacific Journal of Clinical Oncology · 1 citations
https://doi.org/10.1111/ajco.12500
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat